GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Pharma Holding Inc (STU:XQJ0) » Definitions » Shiller PE Ratio

China Pharma Holding (STU:XQJ0) Shiller PE Ratio : (As of Jun. 01, 2024)


View and export this data going back to 2009. Start your Free Trial

What is China Pharma Holding Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


China Pharma Holding Shiller PE Ratio Historical Data

The historical data trend for China Pharma Holding's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Pharma Holding Shiller PE Ratio Chart

China Pharma Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

China Pharma Holding Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of China Pharma Holding's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, China Pharma Holding's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Pharma Holding's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Pharma Holding's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where China Pharma Holding's Shiller PE Ratio falls into.



China Pharma Holding Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

China Pharma Holding's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, China Pharma Holding's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.064/115.2271*115.2271
=-0.064

Current CPI (Mar. 2024) = 115.2271.

China Pharma Holding Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -7.360 98.200 -8.636
201409 -5.820 98.900 -6.781
201412 -20.680 99.000 -24.070
201503 -4.158 99.900 -4.796
201506 1.336 99.500 1.547
201509 3.118 100.500 3.575
201512 -6.426 100.600 -7.360
201603 -1.796 102.200 -2.025
201606 -2.670 101.400 -3.034
201609 -1.782 102.400 -2.005
201612 -3.792 102.600 -4.259
201703 -0.935 103.200 -1.044
201706 -2.225 103.100 -2.487
201709 -2.098 104.100 -2.322
201712 -13.097 104.500 -14.441
201803 -0.405 105.300 -0.443
201806 -0.856 104.900 -0.940
201809 -1.714 106.600 -1.853
201812 -7.911 106.500 -8.559
201903 -0.443 107.700 -0.474
201906 -0.885 107.700 -0.947
201909 -0.908 109.800 -0.953
201912 -19.800 111.200 -20.517
202003 -0.905 112.300 -0.929
202006 0.013 110.400 0.014
202009 -0.849 111.700 -0.876
202012 -1.233 111.500 -1.274
202103 -0.840 112.662 -0.859
202106 -0.830 111.769 -0.856
202109 -0.850 112.215 -0.873
202112 -1.062 113.108 -1.082
202203 -0.999 114.335 -1.007
202206 -0.851 114.558 -0.856
202209 -0.808 115.339 -0.807
202212 -0.925 115.116 -0.926
202303 -0.054 115.116 -0.054
202306 -0.277 114.558 -0.279
202309 -0.281 115.339 -0.281
202312 -0.106 114.781 -0.106
202403 -0.064 115.227 -0.064

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


China Pharma Holding  (STU:XQJ0) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


China Pharma Holding Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of China Pharma Holding's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


China Pharma Holding (STU:XQJ0) Business Description

Traded in Other Exchanges
Address
Second Floor, No. 17, Jinpan Road, Hainan Province, Haikou, CHN, 570216
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

China Pharma Holding (STU:XQJ0) Headlines

No Headlines